NEW YORK CITY (dpa-AFX) - Nasdaq (NDAQ) announced that AstraZeneca PLC - ADR (AZN), will become a component of the NASDAQ-100 Index (NDX) and the NASDAQ-100 Equal Weighted Index (NDXE) prior to market open on February 22, 2022. AstraZeneca PLC - ADR will replace Xilinx Inc. (XLNX) in the NASDAQ-100 Index and the NASDAQ-100 Equal Weighted Index.
Advanced Micro Devices (AMD) is acquiring Xilinx in a transaction expected to be completed on or about February 14.
Copyright(c) 2022 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2022 AFX News
